The results of this study will help in the development of a new type of nasal strip for management of nasal congestion and snoring.

Inclusion Criteria:

• Good general health with (in the opinion of the investigator) no clinically significant and relevant abnormalities of medical history

Exclusion Criteria:

• Currently experiencing cold or flu
• History of perennial or allergic rhinitis or rhinitis medicamentosa
• Evidence of nasal polyps as documented by anterior rhinoscopy
• Evidence of significant nasal tract structural malformations including a severe deviated septum (where subjects are indicated for surgery) or a concha bullosa as documented by anterior rhinoscopy
• Visible open sores, sunburn, irritation, eczema or chronic skin condition on the face to nose
• Bacterial sinusitis infection during 2 weeks prior to entry in the baseline phase of the study
• Any other condition that in the opinion of the investigator would have an affect on nasal breathing
• Use of any product containing menthol within two hours prior to any subjective measures involved in the study
• Had an allergic contact dermatitis on the face within 30 days prior to entry
• History of chronic or active skin or other immunologic (rheumatoid, psoriasis) disease
• History of skin cancer
• Use of antibiotics or alpha adrenergic drugs (all forms) within 1 week prior to entry in the baseine phase of the study
• Use of glucocorticosteroids (all forms) within 1 month prior to entry in the baseline phase of the study
• Any current treatment which in the opinion of the investigator will affect nasal congestion